Uusitupa M, Siitonen O, Härkönen M, Gordin A, Aro A, Hersio K, Johansson G, Korhonen T, Rauramaa R
Horm Metab Res. 1982 Nov;14(11):583-8. doi: 10.1055/s-2007-1019087.
The effects of a beta 1-selective (metoprolol, 150 mg per day) and a non-selective beta-blocking agent (propranolol, 120 mg per day) on metabolic and hormonal responses to physical exercise (a 30 min bicycle ergometer test) were investigated against placebo in seven healthy male volunteers with a double blind cross-over design. The blood glucose level remained unchanged during placebo, it tended to increase during metoprolol, whereas it decreased during propranolol. Both metoprolol and propranolol counteracted the exercise-induced increase in plasma free fatty acids and caused a slight decrease in muscle glycogenolysis. The increase in blood lactate concentration during exercise was not influenced by beta-blockade. The secretion of glucagon and cortisol was not modified significantly by beta-blockade, whereas the growth hormone response to exercise was promoted equally by both beta-blocking agents. It has been assumed previously that, during treatment with beta-blocking agents, diminished hepatic gluconeogenesis, caused by the lack of lactate or free fatty acids, may result in a decline in blood glucose levels. The present results indicate that an inhibition of beta 2-mediated hepatic glycogenolysis by propranolol may also influence blood glucose homeostasis during exercise.
采用双盲交叉设计,在7名健康男性志愿者中,研究了β1选择性阻滞剂(美托洛尔,每日150毫克)和非选择性β阻滞剂(普萘洛尔,每日120毫克)相对于安慰剂对体育锻炼(30分钟自行车测力计测试)的代谢和激素反应的影响。安慰剂期间血糖水平保持不变,美托洛尔期间血糖水平有升高趋势,而普萘洛尔期间血糖水平下降。美托洛尔和普萘洛尔均抵消了运动诱导的血浆游离脂肪酸增加,并导致肌肉糖原分解略有下降。运动期间血乳酸浓度的增加不受β受体阻滞剂的影响。β受体阻滞剂对胰高血糖素和皮质醇的分泌没有显著改变,而两种β阻滞剂均同样促进了运动时生长激素的反应。此前曾假定,在用β阻滞剂治疗期间,由于缺乏乳酸或游离脂肪酸导致肝糖异生减少,可能会导致血糖水平下降。目前的结果表明,普萘洛尔对β2介导的肝糖原分解的抑制作用也可能影响运动期间的血糖稳态。